Inventor · disambiguated record
Jeffrey Bagdanoff
Also filed as: BAGDANOFF JEFFREY · BAGDANOFF JEFFREY T · BAGDANOFF JEFFREY THOMAS
11 granted patents·5 pending applications·51 citations·filing 2007–2022
89Inventor score
Files withNOVARTIS AG6LEXICON PHARMACEUTICALS INC4AUGERI DAVID J2AUGERI DAVID JOHN2BAGDANOFF JEFFREY T2
Top patents by PatentIndex Score
16 records- 0192US7649098B2Imidazole-based compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2007·Granted Jan 19, 2010·20 cites·15 claims
- 0284US7825142B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2009·Granted Nov 2, 2010·6 cites·10 claims
- 0384US7598280B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Oct 6, 2009·6 cites·2 claims
- 0483US10188649B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 29, 2019·3 cites·4 claims
- 0581US10975080B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·3 claims
- 0680US9763937B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2015·Granted Sep 19, 2017·3 cites·4 claims
- 0780US9242996B2Aminoheteroaryl benzamides as kinase inhibitorsBAGDANOFF JEFFREY T·Filed 2014·Granted Jan 26, 2016·5 cites·27 claims
- 0877US8404732B2Methods of treating ulcerative colitisAUGERI DAVID J·Filed 2012·Granted Mar 26, 2013·3 cites·14 claims
- 0974US8093267B2Methods of treating rheumatoid arthritisAUGERI DAVID J·Filed 2009·Granted Jan 10, 2012·1 cites·5 claims
- 1067US10660888B2Aminoheteroaryl benzamides as kinase inhibitorsNOVARTIS AG·Filed 2018·Granted May 26, 2020·0 cites·6 claims
- 1166US2021309663A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1265US8440652B2MST1 kinase inhibitors and methods of their useAUGERI DAVID JOHN·Filed 2012·Granted May 14, 2013·2 cites·17 claims
- 1365US2022089597A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1455US2024309084A1Degradation of extracellular targetsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1548US2011082178A1Methods of treating autoimmune and inflammatory diseases and disordersLEXICON PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1641US2014051681A1Mst1 kinase inhibitors and methods of their useAUGERI DAVID JOHN·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →